Ligand profile
G8G
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_00081 — Acetolactate synthase isozyme 1 large subunit
Identifiers
Database identifiers and provenance.
- Ligand ID
G8G- PDB
6del- UniProt (similar protein)
A0A1D8PJF9- Target protein
- KP13_00081
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 185.4
- −1 ≤ LogP ≤ 5 1.10
- MW ≤ 500 Da 442.3
- LogP ≤ 5 1.10
- H-bond donors ≤ 5 5
- H-bond acceptors ≤ 10 9
- Rotatable bonds ≤ 10 10
- TPSA ≤ 140 Ų 185.4
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
Cc1ncc(c(n1)N)CN(C=O)/C(=C(/CCOP(=O)(O)OP(=O)(O)O)\S)/CCc1ncc(c(n1)N)CN(C=O)/C(=C(/CCOP(=O)(O)OP(=O)(O)O)\S)/C
InChI=1S/C12H20N4O8P2S/c1-8(11(27)3-4-23-26(21,22)24-25(18,19)20)16(7-17)6-10-5-14-9(2)15-12(10)13/h5,7,27H,3-4,6H2,1-2H3,(H,21,22)(H2,13,14,15)(H2,18,19,20)/b11-8-InChI=1S/C12H20N4O8P2S/c1-8(11(27)3-4-23-26(21,22)24-25(18,19)20)16(7-17)6-10-5-14-9(2)15-12(10)13/h5,7,27H,3-4,6H2,1-2H3,(H,21,22)(H2,13,14,15)(H2,18,19,20)/b11-8-
ODQNREFTECDKDB-FLIBITNWSA-NODQNREFTECDKDB-FLIBITNWSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF02775' 'PF02776
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand G8G →
- PDB RCSB structure 6del →
- UniProt UniProt A0A1D8PJF9 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “G8G”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_00081.
PDB 21
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 36
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).